Abstract
Exogenous blood factor products, such as recombinant or human-derived factor VIIa, factor VIII, factor IX, and von Willebrand factor, are crucial for treating various bleeding disorders, but come with high risks and costs. Effective formulary management and development of institutional evidence-based guidelines for blood factor products are essential to maximize patient outcomes and minimize adverse events through an interprofessional approach. This article details the steps and considerations involved for the development of a blood factor product formulary and management at an academic medical center.
References
Arnall, J., Moore, D., Michael, M., Wolcott, M., & Cowgill, N. (2023). Measuring the impact of a pharmacist-driven blood factor education program: A prospective, single-center observational study. Hospital Pharmacy, 58(3), 282–288. https://doi.org/10.1177/00185787221137901
Owen, P., Golightly, L., MacLaren, R., Ferretti, K., & Badesch, D. (2008). Formulary management of recombinant factor VIIa at an academic medical center. Annals of Pharmacotherapy, 42(6), 771–776. https://doi.org/10.1345/aph.1L047
Srivastava, A., Santagostino, E., Dougall, A., Kitchen, S., Sutherland, M., Pipe, S. W., Carcao, M.,…Pierce, G. F. (2020). WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia, 26(Suppl. 6), 1–158. https://doi.org/10.1111/hae.14046
Reardon, D. P., Atay, J. K., Ashley, S. W., Churchill, W. W., Berliner, N., & Connors, J. M. (2015). Implementation of a hemostatic and antithrombotic stewardship program. Journal of Thrombosis and Thrombolysis, 40(3), 379–382. https://doi.org/10.1007/s11239-015-1189-3
Amerine, L. B., Chen, S. L., Daniels, R., Key, N. S., Eckel, S. F., & Savage, S. W. (2015). Implementation of a factor stewardship program to optimize care in hemophilia and bleeding disorders. American Journal of Health-System Pharmacy, 72(18), 1579–1584. https://doi.org/10.2146/ajhp140722
Trueg, A. O., Lowe, C., & Kiel, P. J. (2017). Clinical outcomes of a pharmacy-led blood factor stewardship program. American Journal of Therapeutics, 24(6), e643–e647. https://doi.org/10.1097/MJT.0000000000000371
